In contrast, Gürler et al. found no significant difference between admission CRP levels of patients with advanced cancer and those of patients with early-stage cancer in a study that investigated the effects of chemotherapy on CRP levels and quality of life of patients with cancer [9]. The gene discussed is CRP; the disease is cancer.